iMedix Medical Content Engine 3.13.37

Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

Lymphogranuloma venereum: Causes & Risk Factors - iMedix

Lymphogranuloma venereum

An abstract illustration of Lymphogranuloma Venereum
  • 0 comments

Lymphogranuloma venereum

0 comments

Lymphogranuloma venereum (LGV) is an uncommon sexually transmitted infection that specifically targets the body’s lymphatic system. The disease progresses through distinct stages, often beginning with a minor, painless sore that can go unnoticed. If left untreated, LGV can lead to significant and permanent damage to lymphatic tissues in the genital and rectal regions. This condition requires prompt antibiotic therapy to prevent long-term complications.

What is Lymphogranuloma venereum?

Lymphogranuloma venereum, commonly known as LGV, is a specific and invasive form of sexually transmitted infection. It is caused by distinct strains of the bacterium Chlamydia trachomatis, specifically the serovars L1, L2, and L3. These particular strains behave more aggressively than the ones that cause the more common type of chlamydial infection.

The defining characteristic of LGV is its ability to penetrate beyond the initial site of infection on the skin or mucous membranes and invade the body’s lymphatic system. The disease typically unfolds in three sequential clinical phases. The initial (primary) stage involves a small, temporary genital or rectal lesion. The infection then progresses to a secondary stage, marked by inflammation and swelling of regional lymph nodes (buboes), before potentially advancing to a late (tertiary) stage characterized by chronic tissue destruction and scarring.

Causes:
Lymphogranuloma venereum is directly brought about by a specific bacterium that is transferred between people. The establishment of the infection follows a clear pathway from exposure to invasion of the body's systems.
  • Infection by Specific Bacterial Strains: The sole cause of LGV is infection with the L1, L2, or L3 serovars of the bacterium Chlamydia trachomatis. These particular strains are biologically equipped to be more invasive than the common chlamydial strains, allowing them to cause a more complex, systemic disease.
  • Transmission Through Direct Contact: The bacterium is passed from one person to another during sexual contact. Transmission happens when the mucous membranes of the genitals, anus, or mouth, or a small break in the skin, touch an infectious sore or secretions from an individual with LGV.
  • Initial Site Inoculation: For an infection to begin, the bacteria must breach the body's surface. This occurs at the point of sexual contact, where the bacteria are introduced into the tissue, leading to the formation of an initial, often unnoticed, lesion.
  • Migration to Lymphatic Tissue: A defining causal step of LGV is the bacterium's ability to travel from the entry point. The organisms actively move into the lymphatic system, where they multiply within the lymph nodes, triggering the intense inflammatory response that characterizes the second stage of the disease.
Risk Factors:
While any sexually active person can contract Lymphogranuloma venereum, the infection is not evenly distributed across all populations. The risk of acquiring LGV is significantly concentrated within specific groups and behaviors.
  • Men Who Have Sex with Men (MSM): In Europe, North America, and Australia, outbreaks of LGV have been overwhelmingly concentrated among men who have sex with men. The infection is particularly associated with this demographic.
  • Individuals with HIV: People living with a Human Immunodeficiency Virus (HIV) infection are more susceptible to acquiring LGV. Furthermore, the genital or rectal ulcers caused by LGV can increase the risk of both transmitting and acquiring HIV.
  • Persons with Multiple Sexual Partners: Engaging in sexual activity with multiple or anonymous partners increases the statistical probability of encountering an individual who is infected with LGV, thereby raising the risk of exposure.
  • Geographic Location: Although now seen globally, LGV remains historically endemic and more common in tropical and subtropical regions. This includes parts of the Caribbean, Africa, Southeast Asia, and South America.

Commonly Used Medications for Lymphogranuloma venereum

LGV is a bacterial infection that is curable with a specific course of antibiotics. Treatment should be initiated as soon as possible under the guidance of a healthcare provider.

  • Doxycycline: This is the primary and recommended antibiotic for LGV, typically prescribed for a 21-day period to fully eradicate the invasive bacteria from the lymphatic system.
  • Azithromycin: This antibiotic serves as an effective alternative treatment option, often used when Doxycycline cannot be tolerated.
  • Erythromycin: An older alternative antibiotic, this medication may also be prescribed to cure the infection, particularly in specific patient circumstances like pregnancy.

Where to Find More Information?

For authoritative and detailed information about LGV, including prevention and treatment guidelines, consult these health organizations.

  • Centers for Disease Control and Prevention (CDC): Provides a comprehensive fact sheet on LGV, detailing its transmission, symptoms, and the official treatment recommendations in the United States. https://www.cdc.gov/sti/
  • NHS (UK National Health Service): This resource offers a clear, patient-focused explanation of LGV, covering diagnosis, treatment, and the importance of partner notification. https://www.nhs.uk/

Support

Navigating an LGV diagnosis involves both medical treatment and addressing its impact on sexual health.

  • Sexual Health Clinics: These specialized clinics are the primary resource for confidential testing, receiving expert treatment, and accessing partner notification services to help prevent further spread.
  • Infectious Disease Specialists: For complex or persistent cases, consultation with a doctor specializing in infectious diseases can provide advanced management and care.
  • Partner Notification Counseling: Healthcare providers or public health officials can offer guidance and support in the sensitive process of informing past sexual partners about their potential exposure.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

  • Q&A
There are no questions!

You must login to add a comment.

Popular Questions

Top Members

Join the discussion

Comments are published after moderation. User opinions do not constitute medical advice.

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.

Claim your

By clicking the button below, you accept WebMD's terms of use and
privacy policy. All fields are required unless designated as optional.